Cory Abate-Shen

10PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin for the Treatment of Non-Muscle-Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder.

|Jul 01, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

|May 28, 2026
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

|Jan 09, 2026
TMPO promotes cellular dissemination and metastasis in circulating tumor cells.

Arianna Giacobbe, Aleksandar Z Obradovic, Jinqiu Lu

|Nov 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

|Feb 05, 2025
ATAD2 Drives Prostate Cancer Progression to Metastasis.

Anindita Dutta, Antonio Rodriguez-Calero, Kacey Ronaldson-Bouchard

Pageof 2

Frequent Collaborators

5 joint publications

Andrea Califano

4 joint publications

Juan Martín Arriaga

4 joint publications

Michael M Shen

4 joint publications

Mark A Rubin